Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: Preliminary results from the TREAT Asia HIV Observational Database (TAHOD)

Julian Zhou, N. Kumarasamy, F. Zhang, H. Zhao, N. Han, P. Li, M. P. Lee, Y. M.A. Chen, W. W. Wong, D. C.C. Wang, S. Anand, J. A. Cecelia, S. Pujari, K. Joshi, C. K.C. Lee, S. Kaur, A. Kamarulzaman, R. Ditangco, R. Capistrano, N. I. PatonM. Yap, P. Phanuphak, U. Siangphe, M. Khongphattanayothing, A. Vibhagool, S. Kiertiburanakul, W. Kiatatchasai, J. Chuah, W. Fankhauser, B. Dickson, K. Frost, S. Wong, D. A. Cooper, M. G. Law, K. Petoumenos

研究成果: 雜誌貢獻文章

31 引文 (Scopus)

摘要

Objectives: HIV disease progression has been well documented in Western populations. This study aimed to estimate the short-term risk of AIDS and death from the TREAT Asia HIV Observational Database (TAHOD), a prospective, multicentre cohort study in Asia and the Pacific region. Methods: Prospective data were analysed to estimate short-term disease progression. Endpoints were defined as the time from study entry to diagnosis with AIDS or death. Antiretroviral treatment was fitted as a time-dependent variable. Predictors of disease progression were assessed using Cox proportional hazards models, and prognostic models were developed using Weibull models. Results: A total of 1260 patients with prospective follow-up data contributed 477 person-years of follow-up, during which 18 patients died and 34 were diagnosed with AIDS, a combined rate of 10.1 per 100 person-years. Compared with patients receiving antiretroviral treatment, patients not on treatment had a higher rate of disease progression (17.6 vs. 8.1 per 100 person-years, respectively). Baseline CD4 count was the strongest predictor of disease progression. Prognostic models, using either a baseline CD4 count as the sole marker or markers including baseline haemoglobin, AIDS-related symptoms and previous or current antiretroviral treatment, were successful at identifying patients at high risk of short-term disease progression. Conclusions: Similar to the situation in Western countries, baseline CD4 count was the strongest predictor of short-term disease progression. Prognostic models based on readily available clinical data and haemoglobin level should be useful in estimating short-term clinical risk in HIV-infected patients in Asia and the Pacific region.
原文英語
頁(從 - 到)216-223
頁數8
期刊HIV Medicine
6
發行號3
DOIs
出版狀態已發佈 - 五月 1 2005
對外發佈Yes

指紋

Disease Progression
HIV
Databases
Acquired Immunodeficiency Syndrome
CD4 Lymphocyte Count
Hemoglobins
Time and Motion Studies
Therapeutics
Proportional Hazards Models
Multicenter Studies
Cohort Studies
Population

ASJC Scopus subject areas

  • Health Policy
  • Infectious Diseases
  • Pharmacology (medical)

引用此文

Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region : Preliminary results from the TREAT Asia HIV Observational Database (TAHOD). / Zhou, Julian; Kumarasamy, N.; Zhang, F.; Zhao, H.; Han, N.; Li, P.; Lee, M. P.; Chen, Y. M.A.; Wong, W. W.; Wang, D. C.C.; Anand, S.; Cecelia, J. A.; Pujari, S.; Joshi, K.; Lee, C. K.C.; Kaur, S.; Kamarulzaman, A.; Ditangco, R.; Capistrano, R.; Paton, N. I.; Yap, M.; Phanuphak, P.; Siangphe, U.; Khongphattanayothing, M.; Vibhagool, A.; Kiertiburanakul, S.; Kiatatchasai, W.; Chuah, J.; Fankhauser, W.; Dickson, B.; Frost, K.; Wong, S.; Cooper, D. A.; Law, M. G.; Petoumenos, K.

於: HIV Medicine, 卷 6, 編號 3, 01.05.2005, p. 216-223.

研究成果: 雜誌貢獻文章

Zhou, J, Kumarasamy, N, Zhang, F, Zhao, H, Han, N, Li, P, Lee, MP, Chen, YMA, Wong, WW, Wang, DCC, Anand, S, Cecelia, JA, Pujari, S, Joshi, K, Lee, CKC, Kaur, S, Kamarulzaman, A, Ditangco, R, Capistrano, R, Paton, NI, Yap, M, Phanuphak, P, Siangphe, U, Khongphattanayothing, M, Vibhagool, A, Kiertiburanakul, S, Kiatatchasai, W, Chuah, J, Fankhauser, W, Dickson, B, Frost, K, Wong, S, Cooper, DA, Law, MG & Petoumenos, K 2005, 'Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: Preliminary results from the TREAT Asia HIV Observational Database (TAHOD)', HIV Medicine, 卷 6, 編號 3, 頁 216-223. https://doi.org/10.1111/j.1468-1293.2005.00292.x
Zhou, Julian ; Kumarasamy, N. ; Zhang, F. ; Zhao, H. ; Han, N. ; Li, P. ; Lee, M. P. ; Chen, Y. M.A. ; Wong, W. W. ; Wang, D. C.C. ; Anand, S. ; Cecelia, J. A. ; Pujari, S. ; Joshi, K. ; Lee, C. K.C. ; Kaur, S. ; Kamarulzaman, A. ; Ditangco, R. ; Capistrano, R. ; Paton, N. I. ; Yap, M. ; Phanuphak, P. ; Siangphe, U. ; Khongphattanayothing, M. ; Vibhagool, A. ; Kiertiburanakul, S. ; Kiatatchasai, W. ; Chuah, J. ; Fankhauser, W. ; Dickson, B. ; Frost, K. ; Wong, S. ; Cooper, D. A. ; Law, M. G. ; Petoumenos, K. / Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region : Preliminary results from the TREAT Asia HIV Observational Database (TAHOD). 於: HIV Medicine. 2005 ; 卷 6, 編號 3. 頁 216-223.
@article{2357b0b887114bb7b136d7fb749fcd51,
title = "Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: Preliminary results from the TREAT Asia HIV Observational Database (TAHOD)",
abstract = "Objectives: HIV disease progression has been well documented in Western populations. This study aimed to estimate the short-term risk of AIDS and death from the TREAT Asia HIV Observational Database (TAHOD), a prospective, multicentre cohort study in Asia and the Pacific region. Methods: Prospective data were analysed to estimate short-term disease progression. Endpoints were defined as the time from study entry to diagnosis with AIDS or death. Antiretroviral treatment was fitted as a time-dependent variable. Predictors of disease progression were assessed using Cox proportional hazards models, and prognostic models were developed using Weibull models. Results: A total of 1260 patients with prospective follow-up data contributed 477 person-years of follow-up, during which 18 patients died and 34 were diagnosed with AIDS, a combined rate of 10.1 per 100 person-years. Compared with patients receiving antiretroviral treatment, patients not on treatment had a higher rate of disease progression (17.6 vs. 8.1 per 100 person-years, respectively). Baseline CD4 count was the strongest predictor of disease progression. Prognostic models, using either a baseline CD4 count as the sole marker or markers including baseline haemoglobin, AIDS-related symptoms and previous or current antiretroviral treatment, were successful at identifying patients at high risk of short-term disease progression. Conclusions: Similar to the situation in Western countries, baseline CD4 count was the strongest predictor of short-term disease progression. Prognostic models based on readily available clinical data and haemoglobin level should be useful in estimating short-term clinical risk in HIV-infected patients in Asia and the Pacific region.",
keywords = "AIDS, Disease progression, HIV, Observational Database",
author = "Julian Zhou and N. Kumarasamy and F. Zhang and H. Zhao and N. Han and P. Li and Lee, {M. P.} and Chen, {Y. M.A.} and Wong, {W. W.} and Wang, {D. C.C.} and S. Anand and Cecelia, {J. A.} and S. Pujari and K. Joshi and Lee, {C. K.C.} and S. Kaur and A. Kamarulzaman and R. Ditangco and R. Capistrano and Paton, {N. I.} and M. Yap and P. Phanuphak and U. Siangphe and M. Khongphattanayothing and A. Vibhagool and S. Kiertiburanakul and W. Kiatatchasai and J. Chuah and W. Fankhauser and B. Dickson and K. Frost and S. Wong and Cooper, {D. A.} and Law, {M. G.} and K. Petoumenos",
year = "2005",
month = "5",
day = "1",
doi = "10.1111/j.1468-1293.2005.00292.x",
language = "English",
volume = "6",
pages = "216--223",
journal = "HIV Medicine",
issn = "1464-2662",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region

T2 - Preliminary results from the TREAT Asia HIV Observational Database (TAHOD)

AU - Zhou, Julian

AU - Kumarasamy, N.

AU - Zhang, F.

AU - Zhao, H.

AU - Han, N.

AU - Li, P.

AU - Lee, M. P.

AU - Chen, Y. M.A.

AU - Wong, W. W.

AU - Wang, D. C.C.

AU - Anand, S.

AU - Cecelia, J. A.

AU - Pujari, S.

AU - Joshi, K.

AU - Lee, C. K.C.

AU - Kaur, S.

AU - Kamarulzaman, A.

AU - Ditangco, R.

AU - Capistrano, R.

AU - Paton, N. I.

AU - Yap, M.

AU - Phanuphak, P.

AU - Siangphe, U.

AU - Khongphattanayothing, M.

AU - Vibhagool, A.

AU - Kiertiburanakul, S.

AU - Kiatatchasai, W.

AU - Chuah, J.

AU - Fankhauser, W.

AU - Dickson, B.

AU - Frost, K.

AU - Wong, S.

AU - Cooper, D. A.

AU - Law, M. G.

AU - Petoumenos, K.

PY - 2005/5/1

Y1 - 2005/5/1

N2 - Objectives: HIV disease progression has been well documented in Western populations. This study aimed to estimate the short-term risk of AIDS and death from the TREAT Asia HIV Observational Database (TAHOD), a prospective, multicentre cohort study in Asia and the Pacific region. Methods: Prospective data were analysed to estimate short-term disease progression. Endpoints were defined as the time from study entry to diagnosis with AIDS or death. Antiretroviral treatment was fitted as a time-dependent variable. Predictors of disease progression were assessed using Cox proportional hazards models, and prognostic models were developed using Weibull models. Results: A total of 1260 patients with prospective follow-up data contributed 477 person-years of follow-up, during which 18 patients died and 34 were diagnosed with AIDS, a combined rate of 10.1 per 100 person-years. Compared with patients receiving antiretroviral treatment, patients not on treatment had a higher rate of disease progression (17.6 vs. 8.1 per 100 person-years, respectively). Baseline CD4 count was the strongest predictor of disease progression. Prognostic models, using either a baseline CD4 count as the sole marker or markers including baseline haemoglobin, AIDS-related symptoms and previous or current antiretroviral treatment, were successful at identifying patients at high risk of short-term disease progression. Conclusions: Similar to the situation in Western countries, baseline CD4 count was the strongest predictor of short-term disease progression. Prognostic models based on readily available clinical data and haemoglobin level should be useful in estimating short-term clinical risk in HIV-infected patients in Asia and the Pacific region.

AB - Objectives: HIV disease progression has been well documented in Western populations. This study aimed to estimate the short-term risk of AIDS and death from the TREAT Asia HIV Observational Database (TAHOD), a prospective, multicentre cohort study in Asia and the Pacific region. Methods: Prospective data were analysed to estimate short-term disease progression. Endpoints were defined as the time from study entry to diagnosis with AIDS or death. Antiretroviral treatment was fitted as a time-dependent variable. Predictors of disease progression were assessed using Cox proportional hazards models, and prognostic models were developed using Weibull models. Results: A total of 1260 patients with prospective follow-up data contributed 477 person-years of follow-up, during which 18 patients died and 34 were diagnosed with AIDS, a combined rate of 10.1 per 100 person-years. Compared with patients receiving antiretroviral treatment, patients not on treatment had a higher rate of disease progression (17.6 vs. 8.1 per 100 person-years, respectively). Baseline CD4 count was the strongest predictor of disease progression. Prognostic models, using either a baseline CD4 count as the sole marker or markers including baseline haemoglobin, AIDS-related symptoms and previous or current antiretroviral treatment, were successful at identifying patients at high risk of short-term disease progression. Conclusions: Similar to the situation in Western countries, baseline CD4 count was the strongest predictor of short-term disease progression. Prognostic models based on readily available clinical data and haemoglobin level should be useful in estimating short-term clinical risk in HIV-infected patients in Asia and the Pacific region.

KW - AIDS

KW - Disease progression

KW - HIV

KW - Observational Database

UR - http://www.scopus.com/inward/record.url?scp=21144454512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21144454512&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1293.2005.00292.x

DO - 10.1111/j.1468-1293.2005.00292.x

M3 - Article

C2 - 15876289

AN - SCOPUS:21144454512

VL - 6

SP - 216

EP - 223

JO - HIV Medicine

JF - HIV Medicine

SN - 1464-2662

IS - 3

ER -